Showing 3821-3830 of 19376 results for "".
APP Biosimilar Education Video Series Module 1
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/app-biosimilar-education-video-series-module-1/15966/This series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosiExamining Barriers to Digital Healthcare in PAH
https://reachmd.com/programs/clinicians-roundtable/examining-barriers-to-digital-healthcare-in-pah/56331/While digital health tools hold promise for improving pulmonary arterial hypertension (PAH) care, significant barriers remain in device access, data standardization, and usability. Join Dr. Daniel Lachant as he examines the challenges of integrating wearables into clinical practice and highlRedefining ATTR-CM Care in the Age of Targeted Therapy
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/redefining-attr-cm-care-in-the-age-of-targeted-therapy/49035/A recent review from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council examines the clinical effectiveness, cost-effectiveness, and policy implications of disease-modifying therapies for transthyretin amyloid cardiomyopathy (ATTR-CM). As theseLeveraging AI To Optimize Epilepsy Patient Care
https://reachmd.com/programs/practical-neurology/leveraging-ai-to-optimize-epilepsy-patient-care/39906/Pierre D’Haese, PhD, West Virginia University Rockefeller Neuroscience Institute, Morgantown, WV, discuses how AI-driven automation can surface missing MRIs, EEGs, and neuropsychological evaluations to close diagnostic care gaps in epilepsy management.“Ask Me Anything” Mentorship Session: Dr. Natasha Mesinkovska on Academia, Alopecia Areata, and More
https://reachmd.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-dr-natasha-mesinkovska-on-academia-alopecia-areata-and-more/48814/Natasha Atanaskova Mesinkovsa, MD, PhD, vice chair for clinical research in the UC Irvine School of Medicine's Department of Dermatology, discusses how she navigated her unique career path, how she balances her various responsibilities now, and more in an "Ask Me Anything" mentorship session.Prioritizing Health Equity in Pediatric Practice: Strategies for Meaningful Change
https://reachmd.com/programs/clinicians-roundtable/prioritizing-health-equity-in-pediatric-practice-strategies-for-meaningful-change/37130/Recognizing how inequities can significantly impact pediatric care outcomes is essential to improving access, trust, and long-term health. Dr. Shelina Ramnarine is joined by Dr. Yolanda Evans to discuss actionable strategies that can help us deliver more inclusive care, from social determinant screeTailoring Treatment in Pediatric Meningitis: Age-Based Considerations
https://reachmd.com/programs/clinicians-roundtable/tailoring-treatment-in-pediatric-meningitis-age-based-considerations/37248/Every moment counts when meningitis is suspected. To help reduce the risk of poor neurologic outcomes, Dr. Jessica Snowden is here to review age-based considerations that guide empiric antibiotic and antiviral choices—from neonatal infections acquired at delivery to risks in unvaccinated older childMonitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
https://reachmd.com/programs/project-oncology/monitoring-adverse-events-post-car-t-the-latest-approaches-and-best-practices/35453/This is a non-certified educational series produced and controlled by ReachMD. As CAR T-cell therapy advances, so does the complexity of adverse event monitoring. Due to evolving insights into acute toxicities, infections, cytopenias, and secondary malignancies, both inpatient and outpatient care moMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
https://reachmd.com/programs/neurofrontiers/ms-and-structural-disconnectivity-pathophysiology-and-emerging-technologies/32703/Explore how lesions related to multiple sclerosis can disrupt brain connectivity, leading to cognitive and motor impairments.DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
https://reachmd.com/series/dermwire-tv/dermwiretv-jj-boosts-dermatology-pipeline-new-humira-biosimilar-launched/24561/In this episode of DermwireTV, Johnson & Johnson makes a major acquisition to expand its dermatology treatment pipeline; the first high-concentration, citrate-free biosimilar to Humira is launched in the US; and in the C-Suite Chats feature, the CEO of Benev discusses the medical aesthetic marke